William Vernier

William Vernier has extensive work experience in the biotechnology and pharmaceutical industry.

William is currently serving as an Associate Director at Genesis Therapeutics, a position they started in July 2023. Prior to this, they held the role of Associate Director and Director at Entos, Inc from October 2021 to July 2023.

Before that, William worked as a Principal Scientist at Loxo Oncology at Lilly from November 2020 to October 2021. William also worked at Genentech, where they held multiple roles including Principal Scientific Researcher from September 2020 to November 2020, and Senior Scientific Researcher from May 2018 to August 2020.

William's career began at Pfizer, where they worked as a Senior Scientist from August 2003 to July 2011. William also held the positions of Scientist from 1997 to 2003 and Associate Scientist from 1997 to 2000 at the same company.

Furthermore, they served as a Principal Associate Scientist at Dart Neuroscience from July 2014 to February 2018, and as a Senior Associate Scientist from August 2011 to July 2014.

Additionally, William worked as a Temporary Investigator at the California Institute for Biomedical Research (Calibr) from February 2018 to April 2018.

Overall, William Vernier has significant experience in scientific research and leadership roles within the biotechnology and pharmaceutical industry.

William Vernier started their education at CPE Lyon in 1992, where they pursued a degree in Chemistry. William completed their studies at CPE Lyon in 1995, earning an Engineer Diploma. Following this, they joined The Ohio State University in 1994 and obtained a Master's degree in Organic Chemistry in 1997.